Evidence map›Paper›PMID 41275180›Full record

Observational studyBMC public health2025

Analysis of the time to breast cancer diagnosis in Cuba: an observational study.

Tamalika Koley

Abstract readObservational Study
In one paragraph

Observational study in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Tamalika KoleyDecision Sciences Area, Indian Institute of Management Lucknow, Lucknow, Uttar Pradesh, 226013, India. tamalika.koley@iiml.ac.in.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBreast cancer is the most prevalent cancer diagnosed among Cuban women and the second leading cause of mortality due to cancer, making it a major public health issue. It is necessary to identify the factors affecting the diagnosis time of breast cancer to avoid possible diagnosis delay, thus improving the survival rates. A large number of variables influencing diagnosis time are now available due to recent advancements in technologies for data collection. Standard regression models are inconsistent for modeling these high-dimensional datasets because of their tendency to overfit.

methodsThis study uses a wide range of demographic, biomedical, and socioeconomic variables to provide a detailed understanding of the factors affecting the breast cancer diagnosis time using survival analysis methods. Due to the high volume and huge complexity of the data, survival machine learning methods like random survival forest, classification and regression tree are used for the analysis.

resultsThe analysis identifies age at menopause, BI-RADS (Breast Imaging-Reporting and Data System) category, and the number of biopsies conducted as the key variables affecting the time-to-diagnosis of breast cancer among Cuban women. These findings indicate the key areas that require urgent attention to prevent diagnosis delay.

conclusionsThis study identifies important variables that the administration of Cuba can focus on to develop tailored policies to avoid delays in breast cancer diagnosis. By assessing these gaps in the existing cancer-related initiatives undertaken by the government of Cuba, the development of more effective strategies can be achieved for reducing the overall cancer incidence in the country.

Indexed as

Breast NeoplasmsDelayed DiagnosisAdultAgedCubaEarly Detection of CancerFemaleHumansMiddle AgedSocioeconomic FactorsSurvival AnalysisTime FactorsBreast cancerSurvival AnalysisSurvival machine learning

Identifiers

PMID41275180
PMCPMC12754850

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.